AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05356117 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention Control (AC
Description: Stretching
Study NCT05577078 — intervention group
Intervention type: PROCEDURE
Intervention: Transcatheter edge-to-edge repair (TEER)
Description: Minimally invasive transcatheter-based edge-to-edge repair technique for tricuspid regurgitation
Study NCT06456450 — intervention group
Intervention type: BIOLOGICAL
Intervention: Biological Treatment for severe asthma patients
Description: Biological treatment for severe asthma available in Taiwan and is covered by covered by National Health Insurance
Study NCT04242511 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of tuberculosis medications level
Description: Measurement of tuberculosis medication levels at 2 hours post-dose
Study NCT05462795 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Liquid biopsy for aberrant DNA methylation analysis - Indeterminate pulmonary nodule
Description: 10 cc of blood is collected at one time point, which is prior to biopsy procedure
Study NCT05462795 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Liquid biopsy for aberrant DNA methylation analysis - Known lung cancer for surgical resection
Description: 10 cc of blood is collected at three time points: 1) before surgery; 2) 4-6 weeks post surgery; and 3) 6 months post surgery
Study NCT05462795 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Liquid biopsy for aberrant DNA methylation analysis - Healthy volunteer
Description: 10 cc of blood is collected at one time point
Study NCT05462795 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Liquid biopsy for aberrant DNA methylation analysis - Benign lung disease
Description: 30 cc of blood is collected at one time point
Study NCT04828694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BICX104
Description: Erodable implantable pellet containing 1 g naltrexone and 11 mg magnesium stearate.
Study NCT04828694 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vivitrol
Description: Intramuscular injection containing 380 mg of naltrexone.
Study NCT04687449 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Curcumin therapy
Description: Clear capsules (made of vegetable cellulose) with turmeric extract (500 mg, 95% curcuminoids), Bioperine (5 mg, improves absorption), and inactive ingredients (microcrystalline cellulose, vegetable magnesium stearate, silicon dioxide).
Study NCT04687449 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Clear capsules (made of vegetable cellulose) with inactive ingredients (lactose monohydrate and food color); the capsules will be matched in size and color of the content to the preparation used in the Curcumin capsule.
Study NCT04687449 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: The standard of care for COPD.
Study NCT05536609 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Epineural suture
Description: 2 or three sutures
Study NCT05536609 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-operative treatment
Description: The injured finger is protected in a plaster cast
Study NCT05845216 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ACTIVE Transcranial photobiomodulation (tPBM)
Description: fMRI records before and after ACTIVE Transcranial photobiomodulation (tPBM)
Study NCT05845216 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM Transcranial photobiomodulation (tPBM)
Description: fMRI records before and after SHAM Transcranial photobiomodulation (tPBM)
Study NCT05843123 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory support a
Description: Invasive mechanical ventilation mode
Study NCT05843123 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory support b
Description: Invasive mechanical ventilation mode
Study NCT05240352 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active tDCS
Description: Subjects will receive active dose (constant current intensity of 2mA) from the tDCS device for 30 minutes per session for two weeks with no sessions on Saturday and Sunday (Monday to Friday), and one additional session two and four weeks later
Study NCT05240352 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham tDCS
Description: Subjects will receive a dose from a sham-tDCSthat is, a device which delivers a different pattern of electric current for 30 minutes per session for two weeks with no sessions on Saturday and Sunday (Monday to Friday), and one additional session two and four weeks later
Study NCT05683249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NRCT-101-SR
Description: NRCT-101SR is a sustained release formulation. Subjects ≥ 50 kg LBM receive a total of four 500 mg tablets/day and subjects \< 50kg LBM receive a total of four 375 mg tablets per day.
Study NCT05683249 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study NCT06108180 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry Needling
Description: 3 treatment to eliminate active trigger points that patients have
Study NCT05179720 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: puncture stent-assisted transperineal prostate biopsy
Description: Patients in the experimental group used a puncture stent to assist transperineal prostate biopsy
Study NCT05179720 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: puncture stent-assisted transperineal prostate biopsy
Description: Patients in the experimental group used a puncture stent to assist transperineal prostate biopsy
Study NCT04785339 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: intervention in adult Latinx immigrants
Description: Participants will complete self-report outcome measures at pre (baseline) and post, and they will receive the intervention in-between these assessments. Thus, the time frame for data collection is 10 weeks.
Study NCT05227547 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Thoracic resection surgery
Description: Patients undergoing thoracic resection surgery (pneumonectomy, lobectomy, segmentectomy) for cancer or suspected cancer, including smokers (active or ex-smokers) and non-smokers, with COPD and without COPD, and non-smoking patients.
Study NCT05197023 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1819 injection or placebo
Description: Drug: SHR-1819 injection or placebo Low-dose group, once per week Drug: SHR-1819 injection or placebo High-dose group, once per week
Study NCT05197023 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SHR-1819 injection or placebo
Description: Drug: SHR-1819 injection or placebo Low-dose group, once per week Drug: SHR-1819 injection or placebo High-dose group, once per week
Study NCT05116046 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recifercept
Description: Recifercept
Study NCT05659355 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Constraint Induced Movement Therapy (CIMT)
Description: I will apply CIMT on effected hand to observe the hand dexterity and grip strength
Study NCT05659355 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT)
Description: I will apply Mirror Therapy on effected hand to obeserve the hand dexterity and grip strength
Study NCT04080791 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) System
Description: The participants will undergo daily 30-minute sessions for 8 days of Virtual Reality (VR) with a VR system using commercially available default programs in addition to traditional intensive therapy regimen provided during inpatient rehab.
Study NCT04080791 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard of care
Description: Control group participants will receive the traditional daily 30-minute intensive therapy regimen provided during acute inpatient rehabilitation stroke treatment protocol.
Study NCT04080791 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Control group participants will receive the traditional daily 30-minute intensive therapy regimen provided during acute inpatient rehabilitation stroke treatment protocol.
Study NCT06140212 — intervention group
Intervention type: BEHAVIORAL
Intervention: Montreal Cognitive Assessment (MoCA)
Description: MoCA would be used to assess participants cognitive functioning.
Study NCT06140212 — intervention group
Intervention type: BEHAVIORAL
Intervention: Chinese ICOPE screening tool (self-administration and interview versions)
Description: The ICOPE screening tool would be used to assess participants health status, including cognitive decline, auditory and visual capabilities, mobility restrictions, nutritional status, and depressive symptoms.
Study NCT06140212 — intervention group
Intervention type: BEHAVIORAL
Intervention: Frailty status assessment (Edmonton frail scale and Frailty criteria by Dr. Fried)
Description: The Edmonton frail scale and Frailty criteria by Dr. Fried would be used to assess participants frailty status.
Study NCT05558176 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sildenafil citrate
Description: The same brand of sildenafil citrate (VIAGRA, manufactured by Fareva Amboise Zone Industrielle, 29 route des Industries, 37530 Poce Sur Cisse, France, under authority of Pfizer Inc, NewYork, NAFDAC Reg NO: 04 - 1509, Batch No: 477209; Exp date: 11 - 2024) will be used in the course of the study.
Study NCT05558176 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sildenafil citrate
Description: The same brand of sildenafil citrate (VIAGRA, manufactured by Fareva Amboise Zone Industrielle, 29 route des Industries, 37530 Poce Sur Cisse, France, under authority of Pfizer Inc, NewYork, NAFDAC Reg NO: 04 - 1509, Batch No: 477209; Exp date: 11 - 2024) will be used in the course of the study.
Study NCT04727320 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic acid
Description: Oral TUDCA, once a day, one tablet (250mg) at a time for 6 months
Study NCT04727320 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral placebo, once a day, one tablet at a time for 6 months
Study NCT06171412 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Glu-COACH
Description: peer-mentoring support from a peer of the same cultural identity and access to a private social media group for all Black and Latinx teens
Study NCT06171412 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced standard-of-care (ESOC)
Description: This group will receive ESOC including additional training and support on CGM beyond routine clinical practice.
Study NCT06171412 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced standard-of-care (ESOC)
Description: This group will receive ESOC including additional training and support on CGM beyond routine clinical practice.
Study NCT05001282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ELU001
Description: Folic-acid functionalized C'Dot-Drug-Conjugate (FA-CDC)
Study NCT04629716 — intervention group
Intervention type: OTHER
Intervention: Medical Cannabis
Description: Medical marijuana is defined by Florida state statue 381.986 as all parts of any plant of the genus Cannabis, whether growing or not; the seeds thereof; the resin extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant or its seeds or resin, including low-THC cannabis, which are dispensed from a medical marijuana treatment center for medical use by a qualified patient.
Study NCT05105789 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: BinaxNOW Test
Description: diagnostic test for SARS-CoV-2
Study NCT05105789 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lollipop swab
Description: A lollipop swab, is an oral swab to collect saliva, sucked on like a lollipop for 20 seconds.
Study NCT04894123 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trifluridine/Tipiracil
Description: Trifluridine/tipiracil : 35 mg/m² orally twice a day from day 1 to day 5 every 14 days.~If oxaliplatin is stopped or it is not indicated, trifluridine/tipiracil in monotherapy 35 mg/m² orally twice a day between days 1-5 and days 8-12; repeated every 28 days.
Study NCT04894123 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin : 85 mg/m² intravenous at day 1 every 14 days.
Study NCT05211739 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Lehfilcon A toric contact lenses
Description: FDA-cleared silicone hydrogel toric contact lenses used as indicated
Study NCT05211739 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Comfilcon A toric contact lenses
Description: Commercially available silicone hydrogel toric contact lenses used as indicated
Study NCT05211739 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CLEAR CARE
Description: Hydrogen peroxide-based contact lens cleaning and disinfecting solution
Study NCT05422287 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Glasses
Description: Group 1
Study NCT05422287 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thermomechanical Stimulation Device
Description: Group 2
Study NCT06414915 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib
Description: 250 mg, po, qd, q3w
Study NCT06414915 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: 200mg, iv, q3w
Study NCT06264778 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib
Description: Generic name: Dabrafenib mesylate capsules Dosage form: capsule Specifications: 50mg, calculated as C23H20F3N5O2S2 Usage: Orally The dose of dabrafenib is 150 mg twice daily (equivalent to a total daily dose of 300 mg), taken at least 1 hour before or 2 hours after a meal. If you miss a dose and it is less than 6 hours before the next dose, you should not take it.~Patients who undergo fenestrated decompression will be administered the drug for 8 weeks, with curettage performed between weeks 8 and 9. Patients undergoing curettage will continue to take dabrafenib preoperatively until a few hours before surgery, but ideally, patients will take dabrafenib within 12 hours before surgery.
Study NCT04846374 — intervention group
Intervention type: DEVICE
Intervention: PowerPort
Description: The study will compare pheresis sessions with the old system versus pheresis sessions with one of two new configurations.
Study NCT05217563 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Memory-reframing intervention (Reframe the Pain)
Description: Parents will be taught to reminisce with their children about the vaccination experience by emphasizing positive aspects of the child's pain memory, using less utterances about pain and fear, correcting negative exaggerations in memory, and enhancing children's self-efficacy regarding their ability to cope with pain (e.g., when children used coping methods such as deep breathing, highlighting that they were brave). Parents will be instructed to reminisce with their children about the vaccine experience using the intervention strategies. Parents in the intervention groups will receive text/email reminders to use needle pain management strategies before each second vaccination appointment. Additionally, parents randomized to the intervention groups will receive text/email reminders approximately once every two weeks to use the memory-reframing principles until the second vaccination appointment.
Study NCT05428254 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Capacitive and Resistive Radiofrequency therapy
Description: TECAR or CRRT is electromagnetic waves produced by high frequency electrical current that are able to penetrate very deep and produce a long-lasting heat which stimulates the superficial and dep tissues and produce a potent long-lasting pain-relieving effect. Mild intensity of heat produced by the long wave diathermy may be used to promote proliferation (Hernández-Bule et al., 2014) and improve the vascularization of skin and muscles.~The integration of two operational modes, Capacitive (CAP) and Resistive (RES), makes it possible to combine sub-thermal (electric) and thermal effects. Indiba radiofrequency has output frequency: 448kHz ± 1 kHz with Maximum output power in RES mode: 100 W and in CAP mode: 350 VA. The capacitive used an isolated metal coated electrode acts as a dielectric surface which concentrate the electrical charges near the capacitive electrode While the resistive electrode causing the diffusion of electrical charges which accumulate near bone and soft tissues.
Study NCT05428254 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise therapy
Description: Stretching of the neck extensor, upper fibers of trapezius, levator scapulae and scalenus muscles. stretching is applied for at least 15 seconds and repeated ten times in each session.
Study NCT05945966 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unilateral training group (UTG)
Description: stroke patients will be undergone task-oriented approach using motor relearning program (MRP) and proprioceptive neuromuscular facilitation (PNF) for the hemi-paretic side
Study NCT05945966 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bilateral training group (BTG).
Description: stroke patients will be undergone strength training using frequency, intensity, type, time (FITT) principle to non-hemi-paretic side and task-oriented approach using motor relearning program (MRP) and proprioceptive neuromuscular facilitation (PNF) to hemi-paretic side
Study NCT04877717 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1904
Description: SHR-A1904
Study NCT05528250 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: International Physical Activity Questionnaire (IPAQ)-Short Form ,Anthropometric Measurements and Evaluation Body Weight and Height, Electromyogram (EMG), Digital Dynamometer measurement ,Static Balance Measurements ,Dynamic Balance Measurements ,Tecnobody Balance Measurement , Mini-Balance Evaluation (MiniBESTest) Systems Test ,Y Balance Test ,Flamingo Balance Test ,Modified Borg Scale.
Study NCT05528250 — intervention group
Intervention type: DEVICE
Intervention: Treadmill
Description: Participants will sign a consent form approved by the ethics committee.Before data collection, height, weight, circumference measurements, leg length, thigh area subcutaneous fat measurement, heart rate, blood pressure and saturation values will be recorded. Before the muscle fatigue protocol, the muscle strength, balance assessment and fatigue of the participants will be evaluated. The muscle fatigue protocol will be done with a treadmill. At the end of the muscle fatigue protocol, the necessary evaluations will be made again and the participants will be rested.
Study NCT05101616 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: camrelizumab+chemotherapy
Description: camrelizumab 200mg，ivdrip，q3w； albumin nanoparticle of paclitaxel 260 mg/m2、 ivdrip，d1，q3w； oxaliplatine 85mg/m2、ivdrip，d1，q3w； S-1 40 mg/m2，po, bid，d1\~d14，q3w. 3 cycles.
Study NCT05101616 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: albumin nanoparticle of paclitaxel 260 mg/m2、 ivdrip，d1，q3w； oxaliplatine 85mg/m2、ivdrip，d1，q3w； S-1 40 mg/m2，po, bid，d1\~d14，q3w. 3 cycles.
Study NCT06068660 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Goal-Oriented Care program
Description: The Goal-Oriented Care Interventions The GOC intervention included the following steps: respecting the participant's values in setting goals, considering direct and indirect factors influencing the goals, communicating and setting goals, implementing goal-oriented strategies, and evaluating goals while adjusting the content of the strategies.
Study NCT06068660 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The routine health education
Description: The control group received routine education, which consisted of oral education and provision of educational pamphlets by nurses during hospitalization.
Study NCT06068660 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The routine health education
Description: The control group received routine education, which consisted of oral education and provision of educational pamphlets by nurses during hospitalization.
Study NCT04226807 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early Postpartum Phone Call
Description: Participants receive a phone call 2-3 weeks after birth asking about overall wellbeing, screening for complications and postpartum depression and referring to lactation or WIC as needed.
Study NCT05937633 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transformational Education Programme
Description: An evidence based targeted transformational leadership programme is designed to provide charge nurses an opportunity to develop transformational leadership knowledge and skill.~The programme includes a 2-day activity based educational training. A prereading booklet will be given prior to the educational activity aimed at enhancing the engagement of the participants. The educational programme comprises of the following contents: Concept of leadership and work engagement, transactional and transformational leadership styles, advantages, and disadvantages of transformational leaders. qualities of transformational leaders, 5- Practices of exemplary leadership practice, the 10 commitments of transformational leadership and developing transformational leadership skills.
Study NCT01019291 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Formaldehyde and NO2 (Exposure to indoor pollutants)
Description: Exposure to indoor pollutants (Formaldehyde and NO2) in a randomized way, followed by bronchial challenge test with house dust mite extract.
Study NCT01019291 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (Exposure to indoor pollutants)
Description: Exposure to indoor pollutants (placebo) in a randomized way, followed by bronchial challenge test with house dust mite extract.